IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Jasper Therapeutics Inc

CUSIP: 471871903 | 4 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Stempoint Capital LP3,707,110
0.8% of portfolio›$2.9M
StyleTurnoverLocationFiled
Stempoint Capital LP
3,707,110$2.9M0.8%CoreVery HighNew York, NY2024-02-13